An <i>in vivo</i> genome‐wide shRNA screen identifies BCL6 as a targetable biomarker of paclitaxel resistance in breast cancer
Mohammad Sultan(Dalhousie University), Paola Marcato(Dalhousie University), Brianne M. Cruickshank(Dalhousie University), Jacob T. Nearing(Broad Institute), Margaret L. Dahn(Dalhousie University), Wasundara Fernando(Dalhousie University), Dejan Vidovic(Dalhousie University), Justin M. Brown(Dalhousie University), Krysta M. Coyle(Simon Fraser University), Morgan G. I. Langille(Dalhousie University), Thomas T. Huynh(Dalhousie University), Emily Lamoureaux(Dalhousie University), Carman A. Giacomantonio(Dalhousie University)
Cited by 12
Related Papers
Microbiome differential abundance methods produce different results across 38 datasets
|Nature Communications|2022|963
Denoising the Denoisers: an independent evaluation of microbiome sequence error-correction approaches
|PeerJ|2018|379
Identifying biases and their potential solutions in human microbiome studies
|Microbiome|2021|260
Harnessing the plant microbiome to promote the growth of agricultural crops
|Microbiological Research|2021|217
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
|Blood Advances|2020|120